我们运用导管法治疗６５例中晚期肝癌，巨块型占６１．３％，结节型占２６．１％，弥漫型占２１．６％，患者肿瘤直径约３ｃｍ～１８ｃｍ不等。随访６－３３个月，多数患者治疗后肿瘤缩小，单纯灌注化疗组１２个月生存率为６．６％，化疗＋碘油＋明胶海绵生存率最高为３７．５％，最长的１例，生存３０个月。影响疗效的因素有：（１）肿瘤分期，（２）门静脉癌栓，（３）肝动脉治疗方法。并探讨治疗后并发症的产生原因和预防措施。 We used catheterization for the treatment of 65 cases of advanced liver cancer, massive type accounted for 61.3%, nodular type accounted for 26.1%, diffuse type accounted for 21.6%, patients with tumor diameter of about 3cm ~ 18cm range. After 6-33 months of follow-up, the majority of patients had tumor shrinkage after treatment. The survival rate was only 6.6% after 12 months of chemotherapy alone, and the highest survival rate was 37.5% with chemotherapy + lipiodol plus gelatin sponge. The longest case was 1 case. , survive for 30 months. The factors affecting the efficacy are: (1) tumor staging, (2) portal vein tumor thrombosis, and (3) hepatic artery treatment. And explore the causes of complications after treatment and preventive measures.